Imagion Biosystems Limited (IBX.AX)

AUD 0.02

(5.56%)

Net Income Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual net income in 2023 was -12.47 Million AUD , down -27.17% from previous year.
Imagion Biosystems Limited's latest quarterly net income in 2024 Q2 was -763.41 Thousand AUD , down 0.0% from previous quarter.
Imagion Biosystems Limited reported an annual net income of -9.8 Million AUD in 2022, down -13.54% from previous year.
Imagion Biosystems Limited reported an annual net income of -8.63 Million AUD in 2021, down -10.83% from previous year.
Imagion Biosystems Limited reported a quarterly net income of -763.41 Thousand AUD for 2024 Q1, up 84.07% from previous quarter.
Imagion Biosystems Limited reported a quarterly net income of -7.68 Million AUD for 2023 Q2, down -100.0% from previous quarter.

Annual Net Income Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Net Income of Imagion Biosystems Limited (2023 - 2014)

Year	Net Income	Net Income Growth
2023	-12.47 Million AUD	-27.17%
2022	-9.8 Million AUD	-13.54%
2021	-8.63 Million AUD	-10.83%
2020	-7.79 Million AUD	-42.61%
2019	-5.46 Million AUD	34.52%
2018	-8.34 Million AUD	-7.1%
2017	-7.79 Million AUD	-653.48%
2016	-1.03 Million AUD	76.49%
2015	-4.4 Million AUD	-74.99%
2014	-2.51 Million AUD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-763.41 Thousand AUD	0.0%
2024 Q1	-763.41 Thousand AUD	84.07%
2023 Q2	-7.68 Million AUD	-100.0%
2023 Q4	-4.79 Million AUD	-100.0%
2023 FY	-12.47 Million AUD	-27.17%
2023 Q1	-3.84 Million AUD	5.08%
2023 Q3	-2.39 Million AUD	68.82%
2022 Q3	-2.02 Million AUD	64.87%
2022 Q2	-5.76 Million AUD	-100.0%
2022 FY	-9.8 Million AUD	-13.54%
2022 Q1	-2.88 Million AUD	37.04%
2022 Q4	-4.04 Million AUD	-100.0%
2021 Q2	-1.45 Million AUD	-100.0%
2021 FY	-8.63 Million AUD	-10.83%
2021 Q4	-4.57 Million AUD	-100.0%
2021 Q1	-725.11 Thousand AUD	80.0%
2021 Q3	-2.28 Million AUD	-57.71%
2020 Q1	-869.24 Thousand AUD	64.46%
2020 FY	-7.79 Million AUD	-42.61%
2020 Q4	-3.62 Million AUD	-100.0%
2020 Q3	-1.81 Million AUD	-4.27%
2020 Q2	-1.73 Million AUD	-100.0%
2019 FY	-5.46 Million AUD	34.52%
2019 Q4	-2.44 Million AUD	-100.0%
2019 Q3	-1.22 Million AUD	-23.94%
2019 Q2	-986.69 Thousand AUD	-100.0%
2019 Q1	-493.34 Thousand AUD	76.06%
2018 Q1	-2.1 Million AUD	-15.83%
2018 FY	-8.34 Million AUD	-7.1%
2018 Q4	-2.06 Million AUD	0.0%
2018 Q3	-2.06 Million AUD	2.32%
2018 Q2	-2.1 Million AUD	0.0%
2017 Q3	-1.82 Million AUD	12.28%
2017 FY	-7.79 Million AUD	-653.48%
2017 Q2	-2.07 Million AUD	0.0%
2017 Q1	-2.07 Million AUD	4.87%
2017 Q4	-1.82 Million AUD	0.0%
2016 Q4	-2.18 Million AUD	0.0%
2016 Q1	- AUD	0.0%
2016 FY	-1.03 Million AUD	76.49%
2016 Q2	- AUD	0.0%
2015 Q4	- AUD	0.0%
2015 FY	-4.4 Million AUD	-74.99%
2014 FY	-2.51 Million AUD	0.0%

Peer Net Income Comparison of Imagion Biosystems Limited

Name	Net Income	Net Income Difference
Australian Clinical Labs Limited	23.93 Million AUD	152.118%
BCAL Diagnostics Limited	-6.4 Million AUD	-94.899%
Genetic Signatures Limited	-17.86 Million AUD	30.165%
Genetic Technologies Limited	-12.01 Million AUD	-3.8%
Healius Limited	-645.8 Million AUD	98.068%
Integral Diagnostics Limited	-60.69 Million AUD	79.45%
INOVIQ Ltd	-6.55 Million AUD	-90.315%
Microba Life Sciences Limited	-19.93 Million AUD	37.438%
Monash IVF Group Limited	-6.52 Million AUD	-91.113%
Rhythm Biosciences Limited	-6.85 Million AUD	-81.921%
Sonic Healthcare Limited	511.09 Million AUD	102.441%